🔗 Share this article

A shadow economy for unapproved slimming drugs is being driven by TikTok fitness influencers and sellers on communication apps, based on recent findings.

Experimental Treatment Gaining Traction Via Social Media

Retatrutide, which is still in research studies, is being promoted by social media influencers for its supposed fat-burning properties. Viewers are encouraged to contact these profiles directly for supplier links, while also receiving promotional offers.

Thriving Commerce on Messaging Platforms

Separately, a robust trade exists on Telegram, where groups with thousands of participants share “before and after” images, injection guides and assertions of rapid British shipping. Sellers promote the substance there before redirecting buyers to WhatsApp for transactions.

Understanding Retatrutide

This medication is an experimental injectable created by US drugmaker Eli Lilly. The drug affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could help patients lose up to a quarter of their total weight. Referred to as the “triple G”, the drug is being hailed online as the next Ozempic.

Healthcare Experts Express Concerns

Nevertheless, doctors and pharmacists have warned that the distribution of what is still an unlicensed drug in the United Kingdom is a cause for concern and could lead to users administering products of unknown origin.

Some experts stated the demand for retatrutide could be linked to the rising price of licensed weight loss treatments such as Mounjaro.

Legal Position and Enforcement

Marketing the unapproved drug on social media or messaging apps is illegal in the United Kingdom, as it is an unapproved drug that must not be promoted or distributed for human use under the British medical regulations.

Several influencers try to circumvent the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and supply can still violate pharmaceutical, advertising, and consumer regulations, potentially leading to fines, prosecution or prison.

Service Reaction and Content Elimination

Based on TikTok, the service has taken down violative material and prohibited related hashtags and search suggestions. The organization said it was committed to maintaining the platform safe and investing in strengthening compliance measures.

Online Trading Activities

Research also discovered communities with up to 9,000 participants marketing retatrutide using Telegram's integrated search feature, which operates like a public directory. Typing “retatrutide” instantly brings up groups with thousands of users, populated with photos of slimming results, glowing testimonials and detailed guides for preparing or administering at residence.

After moments of joining one group, a seller shared contact information, where most transactions occur. The seller provided an guidebook and guaranteed delivery within 48 hours. When asked whether the product was authentic, one vendor said: “You can’t be sure.” Another provided a image of a supposed testing documentation. None inquired about weight, medical conditions or past usage.

Item Information and Pricing

Inside these communities, posts display dark colored packages with postal service labels, claiming to include new batches. One message read: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, mixed at home with purified liquid, or ready-to-use injectors usually sold at £160 for 20mg. When questioned how long a pen should be used, sellers give contradictory answers ranging from a few weeks to “depends on your body”.

Platform Oversight and Security Actions

A representative for Telegram stated it actively monitored harmful content on its service including material that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Cautions

“Individuals are administering substances they cannot confirm. Although the research behind retatrutide is sound, these online versions may not include what they claim,” stated a pharmacy expert, the director of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of an online medical service linked the surge in demand to recent price rises for authorized slimming medications such as Mounjaro. “With costs increasing, individuals are turning to social media. But fake treatments are extremely risky. You can’t be certain what’s inside or whether the environment they were made in was sterile,” she explained.

Her staff has previously seen individuals harmed by personal administration from unverified sources. “We recognize the disappointment, but purchasing from messaging apps or WhatsApp is taking chances with your health,” said Wyllie. “These materials could be contaminated or improperly measured.”

Manufacturer Statement

A spokesperson from the pharmaceutical company stated retatrutide was in third stage clinical trials and had not been reviewed or approved by any regulatory agency anywhere in the world. “Therefore at this time no one can market [it] for human use,” they said, noting that any product “misleadingly claiming itself as a company investigational product not yet approved … may expose users to possibly serious medical dangers”.